Australia Infectious Respiratory Disease Diagnostics Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- Infectious Respiratory Disease Diagnostics Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask Prism AI anything about the infectious respiratory disease diagnostics market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Australia infectious respiratory disease diagnostics market highlights
- The Australia infectious respiratory disease diagnostics market generated a revenue of USD 85.4 million in 2024 and is expected to reach USD 104.9 million by 2033.
- The Australia market is expected to grow at a CAGR of 2.4% from 2025 to 2033.
- In terms of segment, reagents was the largest revenue generating product in 2024.
- Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Infectious respiratory disease diagnostics market data book summary
| Market revenue in 2024 | USD 85.4 million |
| Market revenue in 2033 | USD 104.9 million |
| Growth rate | 2.4% (CAGR from 2025 to 2033) |
| Largest segment | Reagents |
| Fastest growing segment | Reagents |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents, Services |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
Other key industry trends
- In terms of revenue, Australia accounted for 0.7% of the global infectious respiratory disease diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China infectious respiratory disease diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,455.0 million by 2033.
There is a noticeable increase in microbiology research activities pertaining to development of novel biomarker based diagnostic due to growing prevalence of infectious diseases, such as tuberculosis. According to the Australian Institute of Health and Welfare, in 2017, about 1 in 7 people in the country is aged 65 & above and they are more prone to acquiring or developing diseases, leading to increased disease burden.
The rising target population, consumer awareness, and technological advancements is expected to drive the market in the near future. In addition, various strategic initiatives by local market players, such as launch of new products, are expected to boost the market growth.
For instance, COVID-19 diagnostics research is driven by funding from sources like Medical Research Future Fund. Moreover, the government has also invested over USD 2.6 million to support R&D on diagnostics.
No credit card required*
Publish Date: Jan 16, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Respiratory Disease Diagnostics Market Scope
Infectious Respiratory Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| QuidelOrtho Corp | View profile | 7,100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | www.quidelortho.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
Australia Infectious Respiratory Disease Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Infectious Respiratory Disease Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 66.63% in 2024.
Horizon Databook has segmented the Australia infectious respiratory disease diagnostics market based on instruments, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
There is a noticeable increase in microbiology research activities pertaining to development of novel biomarker based diagnostic due to growing prevalence of infectious diseases, such as tuberculosis. According to the Australian Institute of Health and Welfare, in 2017, about 1 in 7 people in the country is aged 65 & above and they are more prone to acquiring or developing diseases, leading to increased disease burden.
The rising target population, consumer awareness, and technological advancements is expected to drive the market in the near future. In addition, various strategic initiatives by local market players, such as launch of new products, are expected to boost the market growth.
For instance, COVID-19 diagnostics research is driven by funding from sources like Medical Research Future Fund. Moreover, the government has also invested over USD 2.6 million to support R&D on diagnostics.
- Australia Infectious Respiratory Disease Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Reagents
- Services
- Australia Infectious Respiratory Disease Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Molecular Diagnostics
- Immunoassays
- Microbiology
- Rapid/Point-of-Care Diagnostics
- Other Technologies
- Australia Infectious Respiratory Disease Diagnostics Market Application Outlook (Revenue, USD Million , 2021-2033)
- COVID-19
- Influenza
- Tuberculosis
- Respiratory Syncytial Virus (RSV)
- Non-tuberculosis Mycobacterium Testing
- Bacterial Pneumonia Testing
- Other Respiratory Diseases
- Australia Infectious Respiratory Disease Diagnostics Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Clinics
- Diagnostics Laboratories
- Research Institutes
Reasons to subscribe to Infectious Respiratory Disease Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Infectious Respiratory Disease Diagnostics Market Outlook databook
- Our clientele includes a mix of Infectious Respiratory Disease Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Infectious Respiratory Disease Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Infectious Respiratory Disease Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Australia Infectious Respiratory Disease Diagnostics Market, 2021-2033 (US$M)
Australia Product - Infectious Respiratory Disease Diagnostics Market Statistics, 2024 - 2033 (US$M)
